Thursday, 19 April 2012

Angela Brand (PHGEN II Coordinator, The Netherlands)

Zsuzsanna Jakab (WHO Regional Director for Europe, Denmark)

Karl Freese (European Commission, DG for Health and Consumers)

Jonathan Lal (PHGEN II Project Manager)

Muin Khoury (Centers for Disease Control (CDC), Atlanta, USA)

Nathalie Stieger (Head Government Affairs, Roche, Switzerland)

Domenica Taruscio (EPIRARE Coordinator, Italy)

Stephane Berghmans (Head Biomedical Sciences, European Science Foundation, Forward Look on PM,

Ingeborg Blancquaert (PHGEN II Steering Committee, Canada)

Hans-Peter Dauben (HTA Agency, Germany)

Marisa Papaluca-Amati (EMA, UK)

Adriano Henney (German Virtual Liver Network, Germany)

Michael Morgan (Science Management Consultant, UK,  former Director of Research Partnerships & Ventures at the Wellcome Trust and former Chief Scientific Officer of Genome Canada)

Richard Imrich (Director, Centerfor Moleculr Medicine, Slovak Academy of Sciences)

Mario Fraga (University Institute of Oncology of Asturias, Spain)

Friday, 20 April 2012

Pierre Anhoury (Senior Executive, Accenture, France)  

Hans Westerhoff (Steering Committee ITFoM, VU Amsterdam and University of Amsterdam, The
Netherlands, University of Manchester, UK)

Paolo Balboni (Scientific Director, European Privacy Association, Belgium)

Alexander Haslberger (PHGEN II consortium, University of Vienna, Austria)

Bodo Lange (PHGEN II Consortium, Max Planck Institute for Molecular Genetics, Germany)

Iñaki Gutierrez Ibarluzea (PHGEN II Consortium, Basque Office for HTA, Spain)

Róza Ádány (PHGEN II Consortium, Department of Preventive Medicine, University of Debrecen, Hungary)

Angela Brand (PHGEN II Coordinator, The Netherlands)
A collaborative initiative of:

In association with:

Stay informed
Sign up here:


PHGEN II official website

Follow us at


Conference Secretariat

Conference Management bv

P.O. Box 1308
6201 BH Maastricht
The Netherlands

T +31 (0)43-36 27 008
F +31 (0)84-83 87 854